Physician profile
John E Cebe
NPI 1972595536
$1,624.82
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $789 · 2020: $239 · 2021: $424 · 2022: $173.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $361.44 | 2019-2022 | |
| Amgen INC. | $213.84 | 2019-2022 | |
| Gilead Sciences, INC. | $154.40 | 2019 | |
| Biosense Webster, INC. | $121.12 | 2021 | |
| Edwards Lifesciences Corporation | $111.08 | 2019 | |
| Sanofi-Aventis U.S. LLC | $94.15 | 2019 | |
| Amarin Pharma, INC. | $93.42 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.83 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $80.85 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $70.93 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.53 | 2021-2022 | |
| Pfizer INC. | $45.29 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $23.46 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.07 | 2019 | |
| Abbott Laboratories | $22.29 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $14.67 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.35 | 2019 | |
| Medtronic Vascular, INC. | $11.54 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $11.44 | 2020 | |
| Boston Scientific Corporation | $11.12 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cebe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.